Literature DB >> 12923831

Changes in urinary monoamine excretion in hyperkinetic children.

Marat G Uzbekov1, Eduard Y Misionzhnik.   

Abstract

The pathogenetic mechanisms of hyperkinetic syndrome are not clear and need further investigation. The aim of the study was to find certain features of monoamine metabolism that are characteristic of children with hyperkinetic syndrome (HKS) with special regard to different degrees of severity (i.e. mild HKS and severe HKS ). The levels of L-dopa, dopamine, noradrenaline, adrenaline, homovanillic, vanillylmandelic and 5-hydroxyindoleacetic acids were measured in daily urine of children (7-11 years old) with mild and severe HKS using fluorimetric and chromatographic methods. Severe HKS was characterized by a significant increase of L-dopa (by 186%), dopamine (by 201%) and adrenaline (by 160%) excretion but an unchanged excretion of noradrenaline compared with those with mild HKS. The study revealed principle differences in monoamine metabolism between the mild and severe forms of HKS which may be of importance in deciding different pharmacotherapeutic approaches to use in patients with HKS of differing severity. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923831     DOI: 10.1002/hup.513

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  2 in total

1.  Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia.

Authors:  Ferenc Martenyi; Nikolay N Zavadenko; Natalia B Jarkova; Alexandr A Yarosh; Victoria O Soldatenkova; Leonid M Bardenstein; Irina A Kozlova; Nikolay G Neznanov; Olga I Maslova; Andrey S Petrukhin; Nina K Sukchotina; Valeriy P Zykov
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-07-01       Impact factor: 4.785

2.  Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder.

Authors:  Sinead M Rhodes; David R Coghill; Keith Matthews
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.